Suggested Topics within your search.
Showing 7,841 - 7,860 results of 7,882 for search '((( whole OR while) optimization method ) OR (( whole OR while) optimization methods ))', query time: 3.21s Refine Results
  1. 7841
  2. 7842

    Efficacy test of a Mycoplasma hyorhinis mRNA-LNP vaccine candidate by Eszter Zsófia Nagy, Levente Szeredi, Hiromi Muramatsu, Noémi Nagy, Dénes Grózner, Zsuzsa Kreizinger, Kinga M. Sulyok, Bandana Pangabam, Lilla Tóth, Rachel H.J. Jun, Dorottya Földi, Enikő Wehmann, Miklós Tenk, Norbert Pardi, Miklós Gyuranecz

    Published 2025-08-01
    “…Therefore, the present study aimed to develop a M. hyorhinis mRNA-LNP vaccine candidate. Materials and methods: The selected antigens were highly conserved proteins involved in bacterial adhesion. …”
    Get full text
    Article
  3. 7843
  4. 7844

    Expression characteristics and functional identification of PpD2 gene in peach (Prunus persica) by XIE Hefang, ZHANG Yajia, ZHANG Junjie, LIAN Xiaodong, ZHANG Haipeng, CHENG Jun, WANG Wei, HOU Nan, WANG Lei, ZHENG Xianbo, FENG Jiancan, WANG Xiaobei, TAN Bin

    Published 2025-06-01
    “…These challenges highlight the emergent need to optimize tree architecture and develop labor-saving cultivars to address the developmental bottlenecks in the peach industry. …”
    Get full text
    Article
  5. 7845
  6. 7846
  7. 7847

    Isolation and identification of strawberry anthracnose and fungicide screening in Henan province by SUN Wenbin, ZHANG Jingjing, SONG Yanhong, ZHAO Xia, LI Gang, ZHOU Houcheng, LIU Lifeng

    Published 2025-06-01
    “…Inoculated leaves with strain ZG-2 displayed rot after one week, while the lesion areas caused by the other strains were less than 50%, indicating a lower pathogenicity in comparison to ZG-2. …”
    Get full text
    Article
  8. 7848
  9. 7849

    Analysis of the humoral and cell-mediated immune response in heterologous and homologous SARS-CoV-2 revaccination by O. M. Drapkina, M. G. Chashchin, S. A. Berns, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova, O. A. Litinskaya

    Published 2023-11-01
    “…Studying and selecting optimal revaccination regimens will allow for long-term protection against coronavirus disease 2019 (COVID-19).Aim. …”
    Get full text
    Article
  10. 7850

    Comparative outcomes of revision total knee arthroplasty: a systematic review and meta-Analysis of high tibial osteotomy vs. unicompartmental knee arthroplasty by Peijie Li, Yongjie Qiao, Yingjia Zhou, Jiahuan Li, Zhiqiang Lin, Yafei Cao, Fei Tan, Jiankang Zeng, Xiaoyang Song, Peng Liu, Shuo Ye, Kaipeng Zhuang, Qiuming Gao, Shenghu Zhou

    Published 2025-08-01
    “…The findings are intended to offer valuable insights for optimizing treatment strategies for patients with knee osteoarthritis in clinical practice. …”
    Get full text
    Article
  11. 7851

    The median Effective Dose (ED50) and the 95% Effective Dose (ED95) of alfentanil in inhibiting responses to cervical dilation when combined with ciprofol during hysteroscopic proce... by Run Gao, Shu-Xi Li, Yan-Hong Zhou, Li Xing, Jin-Peng Fu, Jian-Jun Shen, Xin-Zhong Chen, Li-Li Xu

    Published 2025-07-01
    “…The incidence of intraoperative hypotension was lower in patients given 8 µg·kg−1, 10 µg·kg−1, 12 µg·kg−1 alfentanil, and 14 µg·kg−1 alfentanil than those given 0.15 µg·kg−1 sufentanil (P = 0.044), while the incidence of intraoperative desaturation was higher in patients given 14 µg·kg−1 alfentanil than those given 8 µg·kg−1, 10 µg·kg−1, and 12 µg·kg−1 alfentanil, and 0.15 µg·kg−1 sufentanil (P < 0.001). …”
    Get full text
    Article
  12. 7852

    Novel perceptions and insights into the rare hematologic malignancy of acute megakaryocytic leukemia: a multicenter clinical retrospective study by Yuan Liu, Yanquan Liu, Xiaojun Chen, Yue Yin, Zhenyuan Xu, Jiachen Xie, Jianzhen Shen, He Huang, Huidong Guo

    Published 2025-06-01
    “…Clinical trials of new drugs should be prioritized, while close monitoring of measurable residual disease (MRD) should be implemented. …”
    Get full text
    Article
  13. 7853

    Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients by Dominic McGrosso, Dominic McGrosso, Jessica Raygoza, Jessica Raygoza, Avnee J. Kumar, Avnee J. Kumar, Michael T. Y. Lam, Michael T. Y. Lam, Laura A. Barnes, Laura A. Barnes, Sophia Karandashova, Alexia Perryman, Alexia Perryman, Matthew Geriak, Mazen F. Odish, Nicole G. Coufal, Nicole G. Coufal, Nicole G. Coufal, Brian Lichtenstein, George Sakoulas, George Sakoulas, Angela Meier, Victor Nizet, Victor Nizet, Jorge A. Masso-Silva, Jorge A. Masso-Silva

    Published 2025-07-01
    “…IntroductionIntravenous immunoglobulin (IVIG) is a therapy that uses pooled immunoglobulins from thousands of different donors. While it is primarily used to treat immunodeficiency and autoimmune diseases due to its immunomodulatory properties, IVIG has also been used as an off-label therapy for respiratory infections, including COVID-19. …”
    Get full text
    Article
  14. 7854

    Effects of temperature on the pollination biology of Luntai Xiaobai apricot by XIE Lixing, TIAN Baolian, TANG Zhanghu, ZHU Zongcai, Abulaike Niyazi, ZHANG Dahai, LUO Shudong

    Published 2025-04-01
    “…[Methods] The dynamic flowering of Luntai Xiaobai apricot was observed and recorded from March to April 2024. …”
    Get full text
    Article
  15. 7855

    Understanding patient pathways to Mother and Baby Units: a longitudinal retrospective service evaluation in the UK by Nikolina Jovanović, Žan Lep, Giles Berrisford, Aysegul Dirik, Julia Barber, Bukola Kelani, Olivia Protti

    Published 2025-07-01
    “…The simple pathway entailed contact with one clinician/service prior to admission to the Mother and Baby Unit, while the complex pathway involved interactions with two or more clinicians/services before Mother and Baby Unit admission. …”
    Get full text
    Article
  16. 7856

    The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region by Zhuoying Luo, Yue Xia, Yuping Zhao, Haoyang Huang, Ying Deng, Zejiang Zhan, Yingying Huang, Xun Cao, Xi Chen, Jiayu Zhou, Chixiong Liang, Weixiong Xia, Liangru Ke, Xuehua Wei, Jinling Duan, Xing Lv, Hu Liang

    Published 2025-01-01
    “…Abstract Objectives Metastatic nasopharyngeal carcinoma (mNPC) following palliative chemotherapy has high incidence and mortality rates. While maintenance therapy shows promising potential, the optimal strategy remains undefined. …”
    Get full text
    Article
  17. 7857

    Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data studyResearch in contex... by Andrés F. Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativa, Leonardo Rojas, Jairo Zuluaga, Stella Martínez, Lucia Viola, Carlos Carvajal, Juliana Bogoya, Laura Prieto-Pinto, Daniel Samacá-Samacá, Antonio Robles, Joshua Kock, Claudio Martín, Luis Corrales, Luis E. Raez, Vladmir Cordeiro de Lima, Suraj Samtani, Oscar Arrieta

    Published 2025-09-01
    “…Accelerating the introduction of innovative therapies for advanced lung cancer in Latin America represents a significant opportunity to enhance survival rates, instilling hope and optimism while also avoiding substantial PL. Funding: This study was conducted as a research partnership between Roche and CTIC. …”
    Get full text
    Article
  18. 7858

    Deep Learning-Based Cardiac Chamber Segmentation in Magnetic Resonance-Guided Adaptive Radiation Therapy by Xinru Chen, PhD, Yao Ding, PhD, Julius Weng, MD, Carol C. Wu, MD, Yao Zhao, PhD, Angela Sobremonte, BS, Mustefa Mohammedsaid, MS, Zhan Xu, PhD, Xiaodong Zhang, PhD, Joshua S. Niedzielski, PhD, Sanjay S. Shete, PhD, Laurence E. Court, PhD, Zhongxing Liao, MD, Jihong Wang, PhD, Ergys Subashi, PhD, Percy P. Lee, MD, Jinzhong Yang, PhD

    Published 2025-09-01
    “…Adaptive plan greatly reduced individual cardiac chamber dose while maintaining similar target coverage. Conclusions: This study demonstrated the feasibility of using bFFE-SPAIR and T1 mDixon sequences to accurately segment cardiac chambers on a 1.5-T MR-Linac. …”
    Get full text
    Article
  19. 7859

    Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis by Mahnoor Mir, Felipe Soto, Pedro Antonio Amezcua Gomez, Rodrigo Del Rio Arroyo, Adarsh Suresh, Amber Su, Qiong Gan, John Stewart, Roberto Adachi, Diwakar D. Balachandran, Lara Bashoura, Roberto F. Casal, Burton F. Dickey, George A. Eapen, Scott E. Evans, Horiana Grosu, Carlos A. Jimenez, Julie Lin, David E. Ost, Bruce F. Sabath, Vickie R. Shannon, Aung Naing, Jianjun Gao, Jia Wu, Karthik Suresh, Saadia A. Faiz, Mehmet Altan, Ajay Sheshadri

    Published 2025-06-01
    “…The AUROC for BAL lymphocytes to diagnose ICIP was 0.62 (95% CI 0.57–0.67, optimal cutoff 15.5%, sensitivity 69%, and specificity 52%) and the AUROC for eosinophils was 0.61 (95% CI 0.56–0.66, optimal cutoff 1%, sensitivity 58%, and specificity 62%). …”
    Get full text
    Article
  20. 7860

    Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation by Dorit Fabricius, Carolin Ludwig, Carolin Ludwig, Matthias Proffen, Matthias Proffen, Janina Hägele, Janina Hägele, Judith Scholz, Judith Scholz, Christiane Vieweg, Christiane Vieweg, Immanuel Rode, Immanuel Rode, Simone Hoffmann, Simone Hoffmann, Sixten Körper, Sixten Körper, Hubert Schrezenmeier, Hubert Schrezenmeier, Bernd Jahrsdörfer, Bernd Jahrsdörfer

    Published 2025-05-01
    “…This study aimed to elucidate the immune responses, including B cell, plasmacytoid dendritic cell (pDC), and T cell activation, following mRNA booster vaccination.MethodsIn a longitudinal cohort study, 136 individuals received three different vaccination regimens: homologous mRNA, heterologous vector-mRNA-mRNA, or heterologous vector-vector-mRNA vaccinations. …”
    Get full text
    Article